Pharmacoeconomic analysis of clinical efficiency of combined metformin (Siofor) - insulin therapy in patients with type 2 diabetes mellitus

Código QR

Pharmacoeconomic analysis of clinical efficiency of combined metformin (Siofor) - insulin therapy in patients with type 2 diabetes mellitus

Aim. To assess expedience of metformin combination with long-acting insulin, determine optimal doses of metformin for patients with type 2 diabetesmellitus (DM2), and accomplish pharmacoeconomic analysis of clinical efficiency of various therapeutic modalities. Materials and methods. Patients with...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	I Yu Demidova, T V Gorokhova, Yu B Belousov, D Yu Belousov
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2009
Materias:	metformin insulin therapy combined therapy pharmacoeconomic analysis Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/dbec75fcad3644aea6b212d3ed27879b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Pharmacoeconomic simulation of delayed results of the treatment of type 2 diabetes mellitus with modern insulin analogsin comparison with oral hypoglycemic agents
por: Ivan Ivanovich Dedov, et al.
Publicado: (2010)

Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment
por: Tatiana Ivanovna Romantsova, et al.
Publicado: (2013)

The efficacy of therapy with DPP-4 inhibitors combined with insulin in patients with type 2 diabetes mellitus
por: Alexander Sergeevich Ametov, et al.
Publicado: (2011)

Pharmacoeconomic analysis of conservative strategy for the treatment of patients with diabetic foot syndrome in Moscow
por: Marina Fedorovna Kalashnikova, et al.
Publicado: (2011)

Overcoming marked insulin resistance in a patient with type 2 diabetes mellitus by means of insulin pumptherapy
por: Ekaterina Viktorovna Artemova, et al.
Publicado: (2012)

Type 2 Diabetes Mellitus. From the start – combination therapy
por: Francesco Indovina, et al.
Publicado: (2018)

Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
por: Alexander Sergeevich Ametov, et al.
Publicado: (2010)

Lypohypertrophy in patients receiving insulin therapy: state of the art
por: Natalya Ivanovna Volkova, et al.
Publicado: (2011)

Economic benefit of using testosterone gel (used externally) in men with diabetes mellitus and testosterone deficiency
por: Alexandr A. Astapovskiy, et al.
Publicado: (2019)

Insulin therapy during pregnancy in women with type 1 diabetes
por: V V Potin, et al.
Publicado: (2009)

Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region
por: Elena Efimovna Petryaykina, et al.
Publicado: (2009)

Insulin therapy and body weight: benefits of biphasic human insulin analogue NovoMix 30
por: Elena Viktorovna Surkova
Publicado: (2013)

The experience with the use of insulin pump therapy in children and adolescents with type 1 diabetes mellitus
por: Nina Viktorovna Bolotova, et al.
Publicado: (2010)

Early insulin therapy Coordination Council
por: Marina Vladimirovna Shestakova
Publicado: (2012)

Diabetes mellitus due to biliary recurrent pancreatitis. Case report
por: Elena Alexandrovna Kharlashina, et al.
Publicado: (2011)

Statin use and risk of diabetes mellitus
por: Oksana Mikhailovna Drapkina, et al.
Publicado: (2012)

Insulin pump therapy in children with diabetes mellitus: practice of Krasnoyarsk Krai
por: Tatiana Evgen'evna Taranushenko, et al.
Publicado: (2012)

Metformin and cancer mortality
por: Lev Mikhaylovich Bershteyn
Publicado: (2010)

Upgrading Novopen insulin injection systems - 25 years experience
por: Gagik Radikovich Galstyan, et al.
Publicado: (2011)

Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer
por: Lev Mikhaylovich Bershteyn, et al.
Publicado: (2014)

Modern basal insulins: an ongoing story or the start of a new era?
por: Ivan Ivanovich Dedov
Publicado: (2015)

Humalog Mix 25 in the treatment of type 2 diabetes mellitus
por: Vladimir Ivanovich Zoloedov, et al.
Publicado: (2012)

Individual stepwise intensification of insulin analogue therapy in type 2 diabetes mellitus
por: Alexander Sergeevich Ametov, et al.
Publicado: (2012)

The first and only combination of basal and prandial insulin analogs degludec and aspart: the position of Russian endocrinologists
por: M. V. Shestakova, et al.
Publicado: (2021)

Carbohydrate metabolism in menopausal women
por: Olga Rafael'evna Grigoryan, et al.
Publicado: (2009)

Risk of oncological diseases in patients with diabetes mellitus
por: Gagik Radikovich Galstyan
Publicado: (2009)

Effective and safe control of glycemia with insulin Apidra - the recipe for success of type 2 diabetes prophylaxis
por: Elena Valer'evna Biryukova
Publicado: (2011)

Intensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: Perspectives of dapagliflozin
por: Olga Yuryevna Sukhareva, et al.
Publicado: (2016)

Topical problems of diabetes treatment during pregnancy
por: Irina Yur'evna Demidova, et al.
Publicado: (2009)

Multidimensional effects of metformin in patients with type 2 diabetes
por: Lyudmila A. Ruyatkina, et al.
Publicado: (2017)

Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study
por: Natalya Vladislavovna Zaytseva, et al.
Publicado: (2015)

Insulin degludec: a new basal insulin analogue with an ultra-long duration of action. Safety and efficacy in Russian patients with diabetes
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2015)

Birth weight and length in offsprings of mothers with gestational diabetes mellitus due to mutations in GCK gene
por: Natalia A. Zubkova, et al.
Publicado: (2018)

Basal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and Levemir
por: Alsu Gafurovna Zalevskaya, et al.
Publicado: (2010)

Age-adjustment of insulin pump settings in children and adolescents with type 1 diabetes mellitus
por: Dmitriy Nikitich Laptev, et al.
Publicado: (2013)

Efficacy and safety of metformin for the treatment of gestational diabetes: a new approach to the problem
por: Anna I. Sazonova, et al.
Publicado: (2016)

Possible applications of gliptins (dipeptidyl peptidase-4 inhibitors) in patients with type 2 diabetes mellitus on the various modes of insulin therapy
por: Gagik Radikovich Galstyan, et al.
Publicado: (2015)

Priority areas in management of diabetes mellitus type 1 & 2 (following 47th EASD Annual Meeting)
por: Ivona Renata Yarek-Martynova, et al.
Publicado: (2011)

Therapy with biphasic insulin aspart 30/70 (NovoMix 30) improves glycemic control in patients with type 2 diabetes mellitus: resultsfrom a Russian cohort of IMPROVE observational program designed to study safety and efficiency of biphasic insulin aspart 30 inroutine clinical practice
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2010)

Metformin effects to carbohydrate and lipids metabolism in impaired glucose tolerance patients.
por: Alexander Vasil'evich Dreval', et al.
Publicado: (2010)